RECEPTOR BASIS FOR DOPAMINERGIC SUPER-SENSITIVITY IN PARKINSONS-DISEASE

[1] BARBEAU A, 1969, CAN MED ASSOC J, V101, P791

[2] Barbeau A, 1962, MONOAMINES SYSTEME N, P247

[3] BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5

[4] BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787

[5] BURT DR, 1976, MOL PHARMACOL, V12, P800

[6] ANTI-SCHIZOPHRENIC DRUGS - CHRONIC TREATMENT ELEVATES DOPAMINE RECEPTOR-BINDING IN BRAIN [J]. SCIENCE, 1977, 196 (4287) : 327 - 328

[7] BURT DR, 1976, SOC NEUROSCI, V6, P775

[8] BLOCKADE OF APOMORPHINES DISCRIMINATIVE STIMULUS PROPERTIES - RELATION TO NEUROLEPTIC ACTIVITY IN NEUROPHARMACOLOGICAL AND BIOCHEMICAL ASSAYS [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1976, 5 (06) : 671 - 679

[9] AROMATIC AMINO ACIDS AND MODIFICATION OF PARKINSONISM [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (07) : 374 - &

[10] DOPAMINE RECEPTOR-BINDING - DIFFERENTIATION OF AGONIST AND ANTAGONIST STATES WITH H-3-DOPAMINE AND HALOPERIDOL-H-3 [J]. LIFE SCIENCES, 1975, 17 (06) : 993 - 1001

[1] BARBEAU A, 1969, CAN MED ASSOC J, V101, P791

[2] Barbeau A, 1962, MONOAMINES SYSTEME N, P247

[3] BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5

[4] BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787

[5] BURT DR, 1976, MOL PHARMACOL, V12, P800

[6] ANTI-SCHIZOPHRENIC DRUGS - CHRONIC TREATMENT ELEVATES DOPAMINE RECEPTOR-BINDING IN BRAIN [J]. SCIENCE, 1977, 196 (4287) : 327 - 328

[7] BURT DR, 1976, SOC NEUROSCI, V6, P775

[8] BLOCKADE OF APOMORPHINES DISCRIMINATIVE STIMULUS PROPERTIES - RELATION TO NEUROLEPTIC ACTIVITY IN NEUROPHARMACOLOGICAL AND BIOCHEMICAL ASSAYS [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1976, 5 (06) : 671 - 679

[9] AROMATIC AMINO ACIDS AND MODIFICATION OF PARKINSONISM [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (07) : 374 - &

[10] DOPAMINE RECEPTOR-BINDING - DIFFERENTIATION OF AGONIST AND ANTAGONIST STATES WITH H-3-DOPAMINE AND HALOPERIDOL-H-3 [J]. LIFE SCIENCES, 1975, 17 (06) : 993 - 1001